Nuzenio

Journavx

Journavx news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

Acute pain drug Journavx helps drive Vertex growth in second quarter - Managed Healthcare ExecutiveManaged Healthcare Executive · Wed, 05 Aug 2026 15:22:30 GMTLatigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx - fiercebiotech.comfiercebiotech.com · Tue, 04 Aug 2026 11:55:09 GMT[VRTX Q2 2026 Earnings Call] Vertex Lifts 2026 Guidance to $13.1B–$13.2B as CASGEVY Surges 150% and JOURNAVX Scales - finance.biggo.comfinance.biggo.com · Mon, 03 Aug 2026 22:55:00 GMTInvestigational non-opioid LTG-001 reduced acute pain in phase 2b trial - Managed Healthcare ExecutiveManaged Healthcare Executive · Fri, 31 Jul 2026 19:17:33 GMTLatigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx - STATSTAT · Wed, 29 Jul 2026 07:00:00 GMTPhysician Views Results: Latigo's LTG-001 makes strong first impression, but Journavx verdict stays open - FirstWord PHARMAFirstWord PHARMA · Tue, 28 Jul 2026 02:15:14 GMT

Timeline

Wed, 05 Aug 2026 15:22:30 GMTAcute pain drug Journavx helps drive Vertex growth in second quarter - Managed Healthcare Executive
Tue, 04 Aug 2026 11:55:09 GMTLatigo laces up for $247M IPO to fund non-opioid pain drug rival to Vertex’s Journavx - fiercebiotech.com
Mon, 03 Aug 2026 22:55:00 GMT[VRTX Q2 2026 Earnings Call] Vertex Lifts 2026 Guidance to $13.1B–$13.2B as CASGEVY Surges 150% and JOURNAVX Scales - finance.biggo.com
Fri, 31 Jul 2026 19:17:33 GMTInvestigational non-opioid LTG-001 reduced acute pain in phase 2b trial - Managed Healthcare Executive
Wed, 29 Jul 2026 07:00:00 GMTLatigo reports mid-stage success for would-be rival to Vertex’s pain drug Journavx - STAT
Tue, 28 Jul 2026 02:15:14 GMTPhysician Views Results: Latigo's LTG-001 makes strong first impression, but Journavx verdict stays open - FirstWord PHARMA

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Journavx.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.